Cambridge Investment Research Advisors, Inc. Trans Medics Group, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,604 shares of TMDX stock, worth $408,828. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,604
Previous 3,185
18.24%
Holding current value
$408,828
Previous $235,000
66.81%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TMDX
# of Institutions
358Shares Held
29.6MCall Options Held
399KPut Options Held
154K-
Black Rock Inc. New York, NY2.65MShares$415 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.53MShares$397 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.49MShares$233 Million2.41% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$214 Million0.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.15MShares$180 Million3.04% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $5B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...